Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome

Clinical Cardiology

Volumn 35, Issue 4, 2012, Pages 231-236

  Oyama, Jun Ichi ^a   Yamamoto, Hiroaki ^c   Maeda, Toyoki ^a   Ito, Akira ^c   Node, Koichi ^b   Makino, Naoki ^a  

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b SAGA UNIVERSITY   (Japan)

^c Gakkentoshi Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 N,N' DIMETHYLARGININE; BIOLOGICAL MARKER; CD40 LIGAND; FAS LIGAND; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; FOREARM BLOOD FLOW; HUMAN; HYPEREMIA; HYPOTHESIS; MALE; METABOLIC SYNDROME X; OXIDATIVE STRESS; PLETHYSMOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; SLEEP APNEA SYNDROME; TREATMENT DURATION; VALIDITY; VASCULAR DISEASE; VEIN OCCLUSION;

BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; CONTINUOUS POSITIVE AIRWAY PRESSURE; ENDOTHELIUM, VASCULAR; FEMALE; HEALTH STATUS INDICATORS; HEMODYNAMICS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; POLYSOMNOGRAPHY; PROGNOSIS; REGRESSION ANALYSIS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84859766047     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.21010     Document Type: Article

References (28)

1. Gami AS, Witt BJ, Howard DE, et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007; 49: 403-414.
2. McCurry J., Japanese people warned to curb unhealthy lifestyles: health experts urge a return to dietary basics to prevent future health problems. Lancet. 2004; 363: 1126.
3. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009; 6: e1000132.
4. Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000; 342: 1378-1384.
5. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA. 2000; 283: 1829-1836.
6. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163: 19-25.
7. Peker Y, Hedner J, Norum J, et al. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002; 166: 159-165.
8. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest. 2005; 127: 2076-2084.
9. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365: 1046-1053.
10. Shamsuzzaman AS, Gersh BJ, Somers VK., Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003; 290: 1906-1914.
11. Johns MW., A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14:540-545.
12. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999; 2: 667-689.
13. Oyama J, Maeda T, Sasaki M, et al. Green tea catechins improve human forearm vascular function and have potent anti-inflammatory and anti-apoptotic effects in smokers. Intern Med. 2010; 49: 2553-2559.
14. Oyama J, Maeda T, Kouzuma K, et al. Green tea catechins improve human forearm endothelial dysfunction and have antiatherosclerotic effects in smokers. Circ J. 2010; 74: 578-588.
15. Parati G, Lombardi C, Narkiewicz K., Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk. Am J Physiol Regul Integr Comp Physiol. 2007; 293: R1671-R1683.
16. Lind L., Endothelium-dependent vasodilation, insulin resistance and the metabolic syndrome in an elderly cohort: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study. Atherosclerosis. 2008; 196: 795-802.
17. Title LM, Lonn E, Charbonneau F, et al. Relationship between brachial artery flow mediated dilatation, hyperemic shear stress, and the metabolic syndrome. Vasc Med. 2008; 13: 263-270.
18. Chung S, Yoon IY, Shin YK, et al. Endothelial dysfunction and inflammatory reactions of elderly and middle-aged men with obstructive sleep apnea syndrome. Sleep Breath. 2009; 13: 11-17.
19. Tagawa T, Imaizumi T, Endo T, et al. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994; 90: 2285-2290.
20. Higashi Y, Sasaki S, Nakagawa K, et al. Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function. J Am Coll Cardiol. 2001; 37: 863-870.
21. Ryan S, Taylor CT, McNicholas WT., Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation. 2005; 112: 2660-2667.
22. Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002; 105: 2462-2464.
23. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003; 107: 1129-1134.
24. Jelic S, Lederer DJ, Adams T, et al. Vascular inflammation in obesity and sleep apnea. Circulation. 2010; 121: 1014-1021.
25. Suzuki M, Aoshiba K, Nagai A., Oxidative stress increases Fas ligand expression in endothelial cells. J Inflamm (Lond). 2006; 3: 11.
26. Blanco-Colio LM, Martín-Ventura JL, Tuñõn J, et al. Soluble Fas ligand plasma levels are associated with forearm reactive hyperemia in subjects with coronary artery disease: a novel biomarker of endothelial function? Atherosclerosis. 2008; 201: 407-412.
27. Terui K, Haga S, Enosawa S, et al. Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction. Biochem J. 2004; 380 (part 1): 203-209.
28. Stephanou A, Scarabelli TM, Brar BK, et al. Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem. 2001; 276: 28340-28347.